Ocuphire Pharma (OCUP)
(Delayed Data from NSDQ)
$1.26 USD
-0.05 (-3.82%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $1.27 +0.01 (0.79%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-0.30 | 0.00% |
Earnings Summary
For their last quarter, Ocuphire Pharma (OCUP) reported earnings of -$0.30 per share, missing the Zacks Consensus Estimate of -$0.29 per share. This reflects a negative earnings surprise of 3.45%. Look out for OCUP's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.30 per share, reflecting a year-over-year decrease of 220%.
Earnings History
Price & Consensus
Zacks News for OCUP
Intellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Lags Revenue Estimates
OCUP: What are Zacks experts saying now?
Zacks Private Portfolio Services